SCHEMBL30504352

SCHEMBL30504352

O=c1[nH]c(=O)c2cc(Br)cc(F)c2[nH]1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.37
KMT2A Q03164 1/20 0.37
IDH1 O75874 1/20 0.35
CSNK2A2 P19784 1/20 0.35
CSNK2B P67870 1/20 0.35
CSNK2A1 P68400 1/20 0.35
ALDH1A1 P00352 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
CYP19A1 P11511 1/20 0.35
TSHR P16473 1/20 0.35
THPO P40225 1/20 0.35
MTOR P42345 1/20 0.35
HTT P42858 1/20 0.35
HBB P68871 1/20 0.35
PMP22 Q01453 1/20 0.35
GDA Q9Y2T3 1/20 0.34
KDM4E B2RXH2 2/20 0.33
CA12 O43570 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22393852 1.00 PGR (0.37) PGRKMT2AIDH1CSNK2A2CSNK2B
SCHEMBL25206708 0.81 DAO (0.41) PGRKMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL29936825 0.81 DAO (0.41) PGRKMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL7032385 0.81 MAPT (0.40) KMT2AIDH1CSNK2A2CSNK2BCSNK2A1
SCHEMBL29937099 0.78 MAP2 (0.42) PGRALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL27142990 0.78 MAP2 (0.42) PGRALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL7026627 0.78 IDH1 (0.35) KMT2AIDH1CSNK2A2CSNK2BCSNK2A1
SCHEMBL17883917 0.78 KDM4E (0.36) IDH1CSNK2A2CSNK2BCSNK2A1ALDH1A1
SCHEMBL16167174 0.78 GSK3B (0.39) PGRIDH1CSNK2A2CSNK2BCSNK2A1
SCHEMBL25814975 0.76 IDH1 (0.39) KMT2AIDH1CSNK2A2CSNK2BCSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118302418-B Aromatic heterocyclic compound and application thereof 中国科学院上海药物研究所 2025-05-02 CN disclosed
US-20250042862-A1 AROMATIC HETEROCYCLIC COMPOUND AND APPLICATION THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2025-02-06 US disclosed
EP-4431504-A1 AROMATIC HETEROCYCLIC COMPOUND AND APPLICATION THEREOF Shanghai Institute of Material Medica, Chinese Academy of Sciences (CN) 2024-09-18 EP disclosed
CN-118302418-A Aromatic heterocyclic compound and application thereof 中国科学院上海药物研究所 2024-07-05 CN disclosed
CN-116102533-A Aromatic heterocyclic compound and application thereof 中国科学院上海药物研究所 2023-05-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250042862-A1 AROMATIC HETEROCYCLIC COMPOUND AND APPLICATION THEREOF KDM1B, KDM1A, KDM3B PGR 1023/4885KMT2A 38/4885IDH1 92/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.